1. Scientific Committee on Consumer Safety (SCCS) (2012) The SCCS’s notes of guidance for the testing of cosmetic ingredients and their safety evaluation. http://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_s_006.pdf. Accessed 08 June 2015
2. Worth A, Barroso J, Bremer S et al (2014) Alternative methods for regulatory toxicologya state-of the-art review. JRC science and policy reports. Report EUR 26797 EN
3. Steinmetz KL, Spack EG (2009) The basics of preclinical drug development for neurodegenerative disease indications. Neurology 9:S2
4. Dorado MA, Engelhardt JA (2005) The no-observed adverse level in drug safety evaluations: use, issue, and definition(s). Regul Toxicol Pharmacol 42:265–274
5. European Medicines Agency (2010) Guideline on repeated dose toxicity. Committee for Human Medicinal Products. Reference number CPMP/SWP/1042/99 Rev